Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Best AI Mind Mapping Tools for Teams
For teams struggling to transform random ideas into actionable plans, the significance of AI mind-mapping tools continues to grow. No longer will teams need to manually organize every thought; AI can now create maps from prompts, meeting notes, research results, project briefs, or workshop inputs. This is a benefit for making mind mapping quicker; however, [...]
Via Visibility · July 3, 2026
Why Ultra-High-Yield UPS Is Investing $48 Million to Control the Temperaturefool.com
United Parcel Service is in the middle of a turnaround, and changing its customer base has been a key part of the process.
Via The Motley Fool · July 4, 2026
Is Green Thumb Stock Oversold? The Case for 100% Upside.fool.com
It's a rare gem among marijuana stocks, for several reasons.
Via The Motley Fool · July 4, 2026
A New Stablecoin Is Taking Aim at Circle's USDC. Here's What Investors Need to Know.fool.com
Open USD has some big backers, but it still needs to launch its stablecoin.
Via The Motley Fool · July 4, 2026
Ladder Capital's Asset Management Head Sells 35,000 Shares — What's Really at Stake?fool.com
This New York-based REIT specializing in commercial real estate finance reported a significant insider sale in its latest SEC filing.
Via The Motley Fool · July 4, 2026
3 Stocks to Buy on the AI Infrastructure Sell-Offfool.com
Nvidia, AMD, and Micron look like good buys on this pullback.
Via The Motley Fool · July 4, 2026
Vanguard VCIT vs iShares MUB: Which Bond ETF Should You Choose?fool.com
Corporate bonds offer higher yields and lower costs, while municipal bonds deliver tax-exempt income with significantly lower volatility.
Via The Motley Fool · July 4, 2026
Prediction: SPHQ Will Be the Smartest Buy of 2026. Here's Why.fool.com
With geopolitical, inflation, and AI spending risks growing, investors are already pivoting toward higher-quality stocks in 2026.
Via The Motley Fool · July 4, 2026
Vanguard VT vs State Street SPDW Global ETF Showdown. Which World-Spanning Fund Is the Better Buy?fool.com
VT covers some 10,000 stocks worldwide, while SPDW focuses on developed markets ex-US with around 2,000 holdings but a higher yield.
Via The Motley Fool · July 4, 2026
Berkshire Hathaway's Giant Cash Pile Earns More When Rates Stay High. Here's Why That Matters.fool.com
Berkshire Hathaway is ready for a market downturn, but its safe pile of cash is increasingly a valuable asset in and of itself.
Via The Motley Fool · July 4, 2026
These Stocks Could Win as Wall Street Looks Beyond AI Softwaremarketbeat.com
As AI software multiples compress, institutional capital is rotating into aviation, space, and energy hardware stocks including JOBY, RKLB, LUNR, ASTS, and FCEL.
Via MarketBeat · July 4, 2026
Could This Dividend Stock Help Make You Rich Through Compounding?fool.com
This REIT has already made early investors rich.
Via The Motley Fool · July 4, 2026
EPR's CFO Sold Shares at a Premium — Here's the Bet Behind the Stockfool.com
This specialty REIT, focused on experiential real estate, reported a notable insider sale amid a year of double-digit share price gains.
Via The Motley Fool · July 4, 2026
Missed the First Wave of Artificial Intelligence (AI) Stocks? These 2 Aggressive Plays Are Your Second-Chance Buysfool.com
Nebius and CoreWeave are rapidly growing.
Via The Motley Fool · July 4, 2026
Bitcoin ETFs Saw Outflows of $2 Billion in 2 Weeks. Should You Sell?fool.com
This downtrend is an opportunity for those who are patient.
Via The Motley Fool · July 4, 2026
I'm Calling It: This Is the Best AI Stock to Buy in the Second Half of 2026fool.com
This AI stock still trades at a deep discount to its peers.
Via The Motley Fool · July 4, 2026
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?fool.com
Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026.
Via The Motley Fool · July 4, 2026
The $100,000 TFSA Milestone: How to Start Closing the Gap Todayhttps://www.fool.ca/2026/07/04/the-100000-tfsa-milestone-how-to-start-closing-the-gap-today/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=ae024133-b5f9-41fa-bd7b-1be2d1983c8e
A $100,000 TFSA isn’t a finish line, it’s what can happen when contributions are invested instead of left in cash.
Via The Motley Fool · July 4, 2026
Understanding London’s Private Men’s Health Markettalkmarkets.com
By the time Daniel booked his appointment, he had spent six months doing what many men in London do when something intimate starts to feel off: reading lat
Via Talk Markets · July 4, 2026
Hitclub Cổng gametalkmarkets.com
Cập nhật HitClub 2026 với những thông tin mới về ứng dụng, phiên bản mới và các nội dung nổi bật đang được nhiều người quan tâm. Người dùng có thể khám phá
Via Talk Markets · July 4, 2026
Sandisk Stock Was the Biggest Winner in the First Half of 2026. What's Next for the Second Half?fool.com
Sandisk has dominated the S&P 500 so far this year.
Via The Motley Fool · July 4, 2026
Under Which President Did Bitcoin Perform Best? The Answer May Surprise Youbenzinga.com
Benjamin Cowen says Bitcoin's performance under Donald Trump's second term closely mirrors its trajectory during Joe Biden's administration. ...
Via Benzinga · July 4, 2026
3 Canadian Dividend Stocks Yielding up to 6.3% Worth Owning When Growth Falls Out of Favourhttps://www.fool.ca/2026/07/04/3-canadian-dividend-stocks-yielding-up-to-6-3-worth-owning-when-growth-falls-out-of-favour/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=c77c5bdc-0791-4272-acd3-02a3911aa8fb
These Canadian stocks are most likely to maintain and grow their dividends over time, providing reliable passive income.
Via The Motley Fool · July 4, 2026
D.R. Horton Is Defying the Housing Gloommarketbeat.com
D.R. Horton beat Q2 estimates with $7.6 billion in revenue, raised full-year guidance, and returned over $1 billion to shareholders, even as new home demand remains under pressure.
Via MarketBeat · July 4, 2026
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?fool.com
Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, and industry partnerships.
Via The Motley Fool · July 4, 2026